Biogen Inc. buy Needham & Company LLC
Start price
26.07.24
/
50%
€194.45
Target price
26.07.25
€270.72
Performance (%)
-42.63%
End price
27.07.25
€111.55
Summary
This prediction ended on 27.07.25 with a price of €111.55. Massive losses of -42.63% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.360% | -2.360% | 18.836% |
| iShares Core DAX® | 1.232% | 1.501% | 11.288% |
| iShares Nasdaq 100 | 0.695% | -1.949% | 5.586% |
| iShares Nikkei 225® | 2.085% | 11.061% | 31.150% |
| iShares S&P 500 | 0.419% | 0.215% | 4.116% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten